{"url_path":"/sec/upb/8-k/2026-05-13/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/2022626/0001193125-26-220578-index.html","accession_number":"0001193125-26-220578","cik":"0002022626","ticker":"UPB","issuer_name":"Upstream Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2022626/0001193125-26-220578-index.html","primary_entity_key":"0002022626","primary_entity_name":"Upstream Bio, Inc."},"word_count":84,"has_tables":true,"body_markdown":"## Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\n \n\n \n\n99.1\n\n \n\n[Press Release issued by Upstream Bio, Inc. on May 13, 2026, furnished herewith.](upb-ex99_1.htm)\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nUpstream Bio, Inc.\n\n \n\n \n\n \n\n \n\nDate:\n\nMay 13, 2026\n\nBy:\n\n/s/ E. Rand Sutherland\n\n \n\n \n\n \n\nE. Rand Sutherland, M.D.\nChief Executive Officer"}